Alvotech Company Profile

12:40 EST 21st January 2019 | BioPortfolio

Alvotech is a powerful new player in the field of biopharmaceuticals, where current portfolio assets include biosimilar versions of leading monoclonal antibodies molecules. Alvotech is proud to offer its biologics manufacturing capabilities to its partners and to cooperate in the commercialization of its own developed biosimilar pipeline. Its state of the art manufacturing facilities, contract manufacturing for biologics, and in-house clinical capabilities are just a few of the many reasons why Alvotech is the partner of excellence for biosimilar initiatives. Alvotech’s development and manufacturing center will open in early 2016. Alvotech is open for partnerships and licenses for its current biosimilar assets worldwide. Learn more about Alvotech at and connect with the business development team at

News Articles [20 Associated News Articles listed on BioPortfolio]

Fuji Pharma acquires minority stake in Alvotech

Alvotech and Fuji Pharma recently announced an exclusive agreement for development and commercialization of biosimilars in Japan. Fuji´s investment into Alvotech further strengthens the partnership b...

Changchun High & New Forms $200 Million Biosimilar JV with Alvotech of Iceland

Changchun High & New Technology formed a $200 million China biosimilar JV with Alvotech, an Icelandic biotech. Changchun will fund the JV with $100 million while Alvotech will contribute $10 milli...

Alvotech teams with Fuji Pharma for biosimilar portfolio in Japan

Iceland-based Alvotech has signed a deal for commercialisation of its biosimilar portfolio in Japan in an exclusive partnership agreement with...Read More... The post Alvotech teams with Fuji Pharma f...

Alvotech, Fuji Pharma Expand Biosimilars Alliance

Fuji invests $50 million in Alvotech, expands development and commercialization of biosimilars in Japan

Biosimilar partnerships for Alvotech and Pall Biotech

Partnering to develop biosimilars is still in vogue. The latest companies to join the trend include Alvotech with Changchun High & New Technology Industries Group (CCHN) and Pall Corporation’s B...

Fuji Pharma Invests US$50 Million In Alvotech

Japanese firm Fuji Pharma has acquired a minority stake in Alvotech for around US$50 million, shortly after the firms entered...    

Asia Deal Watch: Alvotech Signs On To Biosimilar Manufacturing JV In China

With partner CCHN, Alvotech will help finance construction of a biologics facility in Changchun, China. Novartis will work with Cellular...   

Alvotech makes deal with Fuji Pharma for biosimilars in Japan

Iceland-based biopharmaceutical company Alvotech and Japan-based Fuji Pharma announced on 19 November 2018 that they had entered into an exclusive partnership for biosimilars in Japan.

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers

Adalimumab is an immunosuppressive drug that belongs to the family of anti-TNF agents. It contains a monoclonal antibody produced by biotechnology. It is designed to bind to tumor necrosis...

Companies [1 Associated Companies listed on BioPortfolio]


Alvotech is a powerful new player in the field of biopharmaceuticals, where current portfolio assets include biosimilar versions of leading monoclonal antibodies molecules. Alvote...

More Information about "Alvotech" on BioPortfolio

We have published hundreds of Alvotech news stories on BioPortfolio along with dozens of Alvotech Clinical Trials and PubMed Articles about Alvotech for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alvotech Companies in our database. You can also find out about relevant Alvotech Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record